跳至主要内容
临床试验/NCT04160715
NCT04160715招募中不适用

Korean Idiopathic Pulmonary Fibrosis Registry

Seoul National University Hospital1 个研究点 分布在 1 个国家目标入组 3,000 人开始时间: 2016年1月最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
3,000
试验地点
1
主要终点
survival of IPF

研究概览

简要总结

This is a multicenter prospective registry of IPF patients in South Korea. The Seoul National University Bundang Hospital is the coordination center for the Korean IPF Registry built by a collaboration of the Korean Interstitial Lung Diseases (ILD) Study Group.

详细描述

Korean ILD Study Group includes investigators of 30 hospitals. Demographic, pulmonary function, laboratory data, chest CT findings and hospital course of IPF patients are collected.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
30 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • IPF patients diagnosed by multidisciplinary discussion

排除标准

  • Other interstitial lung diseases except for IPF
  • connective tissue disease-related ILD
  • exposure-related ILD

结局指标

主要结局

survival of IPF

时间窗: through study completion, an average of 1 year

lung function change (FVC, DLCO)

次要结局

  • survival(through study completion, an average of 1 year)
  • incidence of comorbidity(through study completion, an average of 1 year)
  • acute exacerbation(through study completion, an average of 1 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jong Sun Park

Associate professor

Seoul National University Bundang Hospital

研究点 (1)

Loading locations...

相似试验